William Murray‐Brown

William Murray‐Brown

Auto-generated profile, based on publicly available information

William Murray‐Brown

Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, England, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
EPElena Pontarini
Elena Pontarini
WMWilliam James Murray-Brown
William James Murray-Brown
CCCristina Croia
Cristina Croia
DLDavide Lucchesi
Davide Lucchesi
JCJames Conway
James Conway
MBMichele Bombardieri
Michele Bombardieri
Objectives To explore the relevance of T-follicular-helper (Tfh) and pathogenic peripheral-helper T-cells (Tph) in promoting ectopic lymphoid structures (ELS) and B-cell mucosa-associated lymphoid tissue (MALT) lymphomas (MALT-L) in Sjögren’s syndrome (SS) patients. Methods Salivary gland (SG) biopsies with matched peripheral blood were collected from four centres across the European Union. Transcriptomic (microarray and quantitative PCR) analysis, FACS T-cell immunophenotyping with intracellular cytokine detection, multicolor immune-fluorescence microscopy and in situ hybridisation were performed to characterise lesional and circulating Tfh and Tph-cells. SG-organ cultures were used to investigate functionally the blockade of T-cell costimulatory pathways on key proinflammatory cytokine production. Results Transcriptomic analysis in SG identified Tfh-signature, interleukin-21 (IL-21) and the inducible T-cell co-stimulator (ICOS) costimulatory pathway as the most upregulated genes in ELS+SS patients, with parotid MALT-L displaying a 400-folds increase in IL-21 mRNA. Peripheral CD4+CXC-motif chemokine receptor 5 (CXCR5)+programmed cell death protein 1 (PD1)+ICOS+ Tfh-like cells were significantly expanded in ELS+SS patients, were the main producers of IL-21, and closely correlated with circulating IgG and reduced complement C4. In the SG, lesional CD4+CD45RO+ICOS+PD1+ cells selectively infiltrated ELS+ tissues and were aberrantly expanded in parotid MALT-L. In ELS+SG and MALT-L parotids, conventional CXCR5+CD4+PD1+ICOS+Foxp3- Tfh-cells and a uniquely expanded population of CXCR5-CD4+PD1hiICOS+Foxp3- Tph-cells displayed frequent IL-21/interferon-γ double-production but poor IL-17 expression. Finally, ICOS blockade in ex vivo SG-organ cultures significantly reduced the production of IL-21 and inflammatory cytokines IL-6, IL-8 and tumour necrosis factor-α (TNF-α). Conclusions Overall, these findings highlight Tfh and Tph-cells, IL-21 and the ICOS costimulatory pathway as key pathogenic players in SS immunopathology and exploitable therapeutic targets in SS.

28 May 2014 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
CCCristina Croia
Cristina Croia
EAElisa Astorri
Elisa Astorri
WMWilliam Murray‐Brown
William Murray‐Brown
AWAmanda Willis
Amanda Willis
Karl Albert BrokstadKarl Albert Brokstad
Karl Albert Brokstad
MBMichele Bombardieri
Michele Bombardieri
Objective: To examine whether the B cell tropic γ‐herpesvirus Epstein‐Barr virus (EBV) is aberrantly expressed in its latent and lytic forms within ectopic lymphoid structures (ELS) in the salivary glands of patients with Sjögren's syndrome (SS), and to investigate the relationship between EBV dysregulation, B cell activation, in situ differentiation of autoreactive plasma cells, disease‐specific autoantibody production, and cytotoxicity.Methods: Latent and lytic EBV infection in the salivary glands of 28 patients with SS and 38 patients with nonspecific chronic sialadenitis (NSCS), characterized for the presence or absence of ELS, was investigated by reverse transcription–polymerase chain reaction, in situ hybridization, and immunohistochemical/immunofluorescence staining. Glandular versus synovial production of anti−Ro 52, anti–citrullinated protein antibodies (ACPAs), and anti–EBV peptide antibodies was analyzed in situ or in vivo in human SS/SCID and human rheumatoid arthritis/SCID mouse chimeras.Results: EBV dysregulation within inflammatory infiltrates was observed exclusively in ELS+ SS salivary gland tissue, as revealed by latent EBV infection and lytic EBV infection in B cells and plasma cells, respectively. Conversely, epithelial latent membrane protein 2A expression was observed in both patients with SS and patients with NSCS. Importantly, perifollicular plasma cells displaying Ro 52 immunoreactivity were frequently infected by EBV. Furthermore, ELS‐containing SS salivary gland tissue that was transplanted into SCID mice supported the production of anti–Ro 52/anti–La 48 and anti‐EBV antibodies but not ACPAs. Analysis of CD4+ and CD8+ T cell localization and granzyme B expression demonstrated that the persistence of EBV in ELS‐containing SS salivary glands was associated with follicular exclusion of CD8+ T cells and impaired CD8‐mediated cytotoxicity.Conclusion: Active EBV infection is selectively associated with ELS in the salivary glands of patients with SS and appears to contribute to local growth and differentiation of disease‐specific autoreactive B cells.

25 August 2006 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
Kikkeri N NareshKikkeri N Naresh
Kikkeri N Naresh
ILI Lampert
I Lampert
RHR Hasserjian
R Hasserjian
DLD Lykidis
D Lykidis
KEK Elderfield
K Elderfield
GSG W Stamp
G W Stamp
Specimens of bone marrow trephine biopsy (BMT) are transported and fixed in acetic acid–zinc–formalin fixative, decalcified in 10% formic acid–5% formaldehyde and processed with other specimens to paraffin-wax embedding. Sections, 1-μm-thick, are cut by experienced histotechnologists and used for haematoxylin and eosin, Giemsa, reticulin silver and other histological stains. Further, all immunohistochemical procedures used in the laboratory, including double immunostaining, can be used on these sections with no or minimal modifications. About 10 000 BMT specimens have been analysed using this procedure since 1997 and diseases involving the bone marrow have been classified successfully. More recently, standardised polymerase chain reaction-based analysis and mRNA in situ hybridisation studies have been conducted. Excellent morphology with good antigen, DNA and RNA preservation is offered by the Hammersmith Protocol.

26 April 2018 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
JWJing J. Wang
Jing J. Wang
JRJoanne H. Reed
Joanne H. Reed
ACAlex D. Colella
Alex D. Colella
ARAmanda J. Russell
Amanda J. Russell
WMWilliam Murray‐Brown
William Murray‐Brown
TGTom P. Gordon
Tom P. Gordon
Objective: Rheumatoid factors (RFs) are associated with systemic disease in primary Sjögren's syndrome (SS) and may be pathogenic as mixed cryoglobulins. Current detection methods cannot resolve RFs at a molecular level. This study was undertaken to perform the first proteomic and transcriptomic analysis of secreted and membrane‐bound IgM‐RF in primary SS and identify unique heavy‐chain peptide signatures for RF clonotype tracking.Methods: Purified heavy chains of serum RFs from 15 patients with primary SS were subjected to de novo mass spectrometric sequencing. The circulating B cell Ig repertoire was determined by massively parallel sequencing of IGH RNA from matched peripheral blood mononuclear cells (n = 7). RF‐specific heavy‐chain third complementarity‐determining region (CDR3) peptides were identified by searching RF heavy‐chain peptide sequences against the corresponding IGH RNA sequence libraries. Heavy‐chain CDR3 peptides were used as biomarkers to track serum RF clonotypes using quantitative multiple reaction monitoring.Results: Serum RFs were clonally restricted and composed of shared sets of IgM heavy‐chain variable region (Ig VH) 1–69, 3–15, 3–7, and 3–74 subfamilies. Cryoprecipitable RFs from patients with mixed cryoglobulinemia (MC) were distinguishable from nonprecipitating RFs by a higher frequency of amino acid substitutions and identification of stereotypic heavy‐chain CDR3 transcripts. Potentially pathogenic RF clonotypes were detected in serum by multiple reaction monitoring years before patients presented with MC. Levels of Ig VH4–34 IgM‐RF decreased following immunosuppression and remission of MC.Conclusion: Cryoprecipitable RF clonotypes linked to vasculitis in primary SS have different molecular profiles than nonprecipitating RFs, suggesting different underlying mechanisms of production. The combined omics workflow presented herein provides molecular biomarkers for tracking and removal of pathogenic RF clones.

21 December 2017 in Polish Archives of Internal Medicine
Verified
Journal Article
Open access
WMWilliam Murray‑Brown
William Murray‑Brown
MWMihir D Wechalekar
Mihir D Wechalekar
MSMalcolm Smith
Malcolm Smith

1 June 2017 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
EPE Pontarini
E Pontarini
WMW Murray-Brown
W Murray-Brown
CCC Croia
C Croia
EAE Astorri
E Astorri
DLD Lucchesi
D Lucchesi
MBM Bombardieri
M Bombardieri
Background B/T cell aggregates in the salivary glands (SG) of Sjögren's syndrome (SS) can give rise to ectopic lymphoid structures (ELS) forming ectopic germinal centers (GCs), which has been linked to the development of MALT lymphoma (MALT-L). T follicular-helper cells (Tfh) and T follicular-regulatory cells (Tfr) are specialized CD4+ T-cells that positively and negatively regulate, respectively, the magnitude of the GCs response and the onset of autoimmunity. Objectives To characterize the infiltration of Tfh and Tfr in the SG infiltrates of patients with SS in the context of the presence/absence of ectopic GCs and in subjects with MALT-L. Methods SG biopsies with matching histology and RNA from 37 SS and 38 non-specific chronic sialadenitis (NSCS) patients were stratified as ELS-/ELS+ based on CD3/CD20/CD21/CD138 immunostaining (IHC). Histological samples and mRNA from 12 parotid MALT-L were also studied. Gene expression was measured by Taqman rt-PCR. Multicolor immunofluorescence/confocal microscopy for CD3, CD4, CD45RO, ICOS, PD1, BCL6 and FoxP3 was used to identify Tfh and Tfr. Results Tfh (CD4+CD45RO+PD1+ICOS+FoxP3-) cells and Tfr (CD4+CD45RO+PD1+ICOS+FoxP3+) cells were strongly enriched in ELS+ vs ELS- SS samples. The Tfh:Tfr ratio in ELS+ SG was approximately 2:1. Interestingly, while in tonsils Tfr were routinely detected within GCs, in ELS+ SG Tfr were predominantly excluded from the B cell follicles and accumulated in the T cell rich areas at the periphery of the lymphoid aggregates. Conversely, Tfh densely infiltrated the B cell rich areas and, within ectopic GCs, acquired BCL6. Furthermore, Tfh infiltration closely correlated with SG IL-21 mRNA expression, which in turn was strongly correlated with CD3, CD20 and CD138 IHC scores and with CXCL13, LTb, BAFF, AID and Pax5 gene expression. Finally, MALT-L samples displayed 10-fold higher IL-21 mRNA and twice as much PD1+ICOS+BCL6+ Tfh-cells/field compared to ELS+ SS samples. Conclusions Within the SG of SS patients Tfh cells closely segregate with lesional IL-21 expression, localize within ELS and are strongly enriched during MALT-L development. Conversely, although Tfr cells are also recruited to ELS+ SG in SS patients, we consistently demonstrated follicular exclusion of this subset from ectopic GCs. This suggests that Tfr in SS SG fail to exert their physiological immunoregulatory properties in controlling the magnitude of the GCs response and B cell autoreactivity, as observed in tonsils. Acknowledgements This work was supported by project grants from the Medical Research Council (MR/N003063/1 to MB) and Arthritis Research UK (grant 20089 to MB). Disclosure of Interest E. Pontarini: None declared, W. Murray-Brown: None declared, C. Croia: None declared, E. Astorri: None declared, D. Lucchesi: None declared, N. Lepse: None declared, N. Sutcliffe: None declared, A. Tappuni: None declared, C. Pitzalis: None declared, M. Bombardieri Consultant for: Amgen/Medimmune, GSK and UCB